Folate Status and DNA Damage in Breast Cancer Patients
Author Information
Author(s): Hussien M M I, McNulty H, Armstrong N, Johnston P G, Spence R A J, Barnett Y
Primary Institution: Breast Surgery Unit, Belfast City Hospital
Hypothesis
The study aims to compare folate status and levels of DNA damage between breast cancer and benign breast disease control patients.
Conclusion
Breast cancer patients had significantly higher levels of DNA damage compared to benign breast disease control patients, although differences in folate status were not statistically significant.
Supporting Evidence
- Breast cancer patients had a mean tail moment of DNA damage significantly higher than controls.
- Lower red cell folate levels were observed in breast cancer patients compared to controls.
- DNA damage was positively correlated with alcohol intake in breast cancer patients.
Takeaway
This study looked at how folate levels and DNA damage are related in women with breast cancer compared to those with benign breast issues, finding more DNA damage in cancer patients.
Methodology
Fasting blood samples were taken from breast cancer patients and benign breast disease controls to measure red cell folate and plasma homocysteine, and DNA damage was analyzed using the comet assay.
Limitations
The study had a small sample size, which may limit the ability to detect significant differences.
Participant Demographics
64 breast cancer patients (mean age 57 years) and 30 benign breast disease control patients (mean age 51 years).
Statistical Information
P-Value
P=0.24 for RCF, P=0.073 for plasma homocysteine, P<0.0001 for DNA damage.
Confidence Interval
95% confidence interval for RCF in breast cancer patients was 339.07 (333.3–404.6) vs 379.5 (335.8–505.2) in controls.
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website